myuzaki@keio.jp

2026 Greetings for the year：

2025He reached retirement age at the end of March 2018 and left the Keio University School of Medicine.、From April 1st, he moved to the Keio University Human Biology-Microbiome-Quantum Computation Research Center (WPI-Bio2Q) as a specially appointed professor and special assistant to the center director.、We are continuing our research in Shinanomachi.。Until now, we have been working to create and remove the mechanisms of synapses that make up the neural circuits of the brain.、Although we have been elucidating this at the molecular level,、What's going forward?、Utilizing the technical foundations we have cultivated through our research into the central nervous system,、Focusing on synaptic formation mechanisms in the peripheral, autonomic, and enteric nervous systems、we aim to clarify the linkage between the nervous system and multiple organs, and the pathology caused by its failure, and to develop new treatments.。

As for classroom personnel、2026From April 1st, Assistant Professor Itaru Arai will be transferred to Tokyo University of Science.、You will be developing your research in a new location.。

Award-related news、2025Gordon Research Conference held in New Hampshire from June 8th to 13th. (The topic was on the Excitatory Synapses and Brain Function) Mitsuhiro Oishi, a graduate student, gave a poster presentation at、We accomplished the great feat of being selected for the best poster award out of many poster presentations.。Additionally, Assistant Professor Thomas Chater won the Best Poster Award at the 4th UK-Japan Neuroscience Symposium held at the University of Cambridge in March 2026, earning him an invitation to the 5th UK-Japan Neuroscience Symposium.。

Regarding research funding, in November 2024, we will conduct a moonshot research project, ``Research on the development of reservoir function and its enhancement method that supports brain resilience to overcome dementia (PM:Kyoto University Isa)、2025In February, GTIE GAP Fund “Commercialization of Artificial Dopamine Synapse Connector”："Development of Parkinson's disease treatment that repairs and regenerates neural circuits"、In August 2025, the AMED neuroscience integrated program “Elucidation of the mechanism of dopamine synapse repair for the development of disease-modifying therapy for Parkinson's disease” was adopted.。By advancing the elucidation of the principles of synapse formation、Aiming to develop new therapeutic strategies targeting synapses for dementia and Parkinson's disease。Continuing again、In international leading research、France (Bordeaux IINS):Interdisciplinary Institute for Neuroscience）、America(The Max Planck Institute for Neuroscience) and Japan (Keio University, Kyoto University, Tokyo University, Niigata University, and Genetics Research Institute) will work together to advance memory research。

I look forward to your further guidance and encouragement. Thank you.。

—-My introduction, as usual—–

Thing that I like：
-Scientific discussion。
- Hanging around in the bookstores and stationery shops。I also like the electrician。
- Reading (promiscuously)。I have read all of Akira Yoshimura, Nanao Shiono, Mari Yonehara, Takamasa Kadota, and Yu Sato.。
- To eat delicious foods。I was gaining weight monotonously, but after receiving the results of my health check (fatty liver) in November 2024, I successfully lost 5kg.。

Things that I don't like：
· Formalities and pretenses。It's good to be "honest."。
- Wasabizuke (Pickled Japanese horseradish)。Rakkyo (Pickles Japanese shallots)。Nara pickles。
･ Hair decline trend - a lull。

EssaySee also。

Asahi Shimbun Apital "The Beauty and Mysteries of Nerve Cells: Towards Truly Useful Research"Here。

Keio University School of Medicine, Special Feature “The future led by the birth of CPTX, a substance that connects broken neural circuits” is here。

2022Round-table discussion at Mita Hyoron in MarchClick here for "Forefront of Brain Science Research"。

e le c te ricClick here for the interview。

ResumeHere。